Abstract: Cancer stem cells may mediate therapy resistance and recurrence in various types of cancer, including glioblastoma. Cancer stemlike cells can be isolated from long-term cancer cell lines, including glioma lines. Using sphere formation as a model for cancer cell stemness in vitro, we derived sphere cultures from SMA-497, SMA-540, SMA-560, and GL-261 glioma cells. Gene expression and proteomics profiling demonstrated that sphere cultures uniformly showed an elevated expression of stemness-associated genes, notably including CD44. Differences in neural lineage marker expression between nonsphere and sphere cultures were heterogeneous except for a uniform reduction of -III-tubulin in sphere cultures. All sphere cultures showed slower growth. Self-renewal capacity was influenced by medium conditions but not nonsphere versus sphere culture phenotype. Sphere cultures were more resistant to irradiation, whereas both nonsphere and sphere cultures were highly resistant to temozolomide. Nonsphere cells formed more aggressive tumors in syngeneic mice than sphere cells in all models except SMA-560. There were no major differences in vascularization or infiltration by T cells or microglia/macrophages between nonsphere and sphere cell-derived tumors implanted in syngeneic hosts. Together, these data indicate that mouse glioma cell lines may be induced in vitro to form spheres that acquire features of stemness, but they do not exhibit a uniform biologic phenotype, thereby challenging the view that they represent a superior model system. sphere cultures showed slower growth. Self-renewal capacity was influenced by medium conditions, but not non-sphere versus sphere culture phenotype. Sphere cultures were more resistant to irradiation whereas both non-sphere and sphere cultures were highly resistant to temozolomide. Non-sphere cells formed more aggressive tumors in syngeneic mice than sphere cells in all models except SMA-560.
Introduction
Glioblastomas are highly aggressive intrinsic brain tumors that may develop at all age groups, with incidence steadily increasing with age. Despite multimodal treatment of surgery followed by radiotherapy and alkylating agent chemotherapy, the median survival of glioblastoma patients is still in the range of less than one year in populationbased studies (1) . Effective treatments may be impeded by the high morphological, phenotypic and genetic cellular diversity.
A specific subpopulation of tumor cells, variably termed glioma stem cells or gliomainitiating cells, has been identified in human glioblastomas and has been proposed to confer therapy resistance and tumor progression despite multimodal therapy (2) (3) (4) .
Glioma stem cells are believed to be responsible for tumor initiation and growth due to their unlimited self-renewal capacity and the ability to give rise to more differentiated tumor cells in the tumor bulk. Furthermore, they have been proposed to express specific DNA damage response proteins as well as drug efflux proteins in response to radiotherapy and chemotherapy with DNA alkylating agents such as temozolomide (TMZ) (5-7).
Neural stem cell culture conditions have been used as a standard method to isolate and selectively expand glioma stem cells as tumor spheres that resemble neurospheres in culture, not only from resected primary gliomas ex vivo, but also from C6 rat and U373MG, A172 and U87MG human glioma cell lines (2-4, 8, 9) . Reports on the size of the cell population isolated from the C6 rat glioma cell line that displayed these stem cell characteristics varied from 4% to 87% (9, 10) . Similar to neural stem cells, the putative 5 cancer stem cells from glioma cell lines have been shown to be capable of clonal growth, to exhibit multi-lineage differentiation potential, and to share the expression of various neural stem/progenitor cell markers, including CD133, nestin, Musashi-1 and Sox2 (8, (10) (11) (12) (13) . These neural stem cell characteristics as well as their in vivo tumorigenicity are among the criteria used to identify glioma stem cells.
The best choice of experimental model for glioma research depends on the type of scientific question to be addressed (14) . GL-261 and SMA cell lines are the most commonly used syngeneic mouse glioma models (15) (16) (17) . Here, we systematically addressed the question whether sphere cultures can be derived from these cell lines and whether these preferentially exhibit features of stemness, including enhanced selfrenewal, stem cell marker expression, multi-lineage differentiation potential, resistance to radiotherapy and chemotherapy, and tumorigenicity in vivo. (Gibco), 20 ng/ml basic fibroblast growth factor (FGF) and 20 ng/ml epidermal growth factor (EGF) (Peprotech, London, UK), 6.3 U/ml heparin (Sigma, St. Louis, MO), and 2 mM glutamine (NB medium) at a density of 50,000 cells/ml. Sphere cultures were cultured until the 3 rd passage prior to use for experiments, with a passage duration of approximately 7 days.
Materials and Methods

Materials
Cell growth and doubling times
Non-sphere (2,000/ml) or sphere (20,000/ml) cells were seeded in 25 cm 2 flasks (TPP Techno Plastic Products AG, Trasadingen, Switzerland) in their respective medium.
Every day for non-sphere and every two days for sphere cultures, an aliquot of the cells was dissociated into single cell suspensions using TrypLExpress cell dissociation reagent (Gibco), stained with 0.4% trypan blue, and viable cells were counted using
Neubauer chambers (VWR International AG, Dietikon, Switzerland). Cell counts from three separate experiments were obtained.
Limiting dilution assay
Non-sphere cells were seeded in duplicate in 0. 
Immunofluorescence microscopy
To analyze the expression of neuronal stem cell, mature neuronal and glial cell markers, sphere cultures were prepared as cytospin samples whereas non-sphere cultures were grown on sterilized 11 mm glass coverslips (Assistent 1001/12) coverslips at 5,000 cells in a 24 well plate until they were 80-90% confluent. Spheres that had reached a size of 150-200 µm in diameter were harvested by centrifugation at 700 rpm for 5 min and resuspended in 1200 µl of NB medium. 100 µl of resuspended spheres were cytospun using the Cytospin 4 (Thermo Scientific, Wohlen, Switzerland) at 650 rpm for 4 min. 
TMZ exposure
Cells were seeded in 0.5 ml of their respective medium and plated into 24 well plates for limiting dilution assays or 96 well plates for clonogenic survival assays. On the next day the cells were treated with 0 (serum-free), 10, 100 or 1000 µM TMZ diluted in serumfree DM medium or complete NB medium for 24 h. After that the cells were cultured in fresh complete DM or NB medium and allowed to grow. Colonies or spheres were counted, or Alamar Blue assays were performed as described above.
In vivo experiments
The standard operating procedure and the treatment of all animals were according to were euthanized using a pre-randomization scheme when any mouse in the experiment became symptomatic in order to perform histological studies to assess tumor growth at an early stage ( Table 1 ). The other 9 mice (8 mice for the GL-261 model) were euthanized when displaying neurological symptoms and were thus used for survival analysis (pooled from two separate experiments) and these along with the rest of the brains collected at termination of the experiment, day 80 after implantation, were used for further immunohistochemical stainings. All brains collected upon euthanization were embedded in cryomoulds in Shandon Cytochrome yellow (Thermo Scientific) and frozen in liquid nitrogen. Tumor incidences were determined using hematoxylin and eosin stainings of 8 mm thick cryosections cut using the Microm HM560 (Microchom HM560, Thermo Scientific) before constructing and analyzing Kaplan Meier survival curves using the log-rank test in GraphPad Prism 5.0 software.
Immunohistochemical analysis
Cryosections were fixed in ice-cold acetone for 10 min, washed in PBS and treated with 3% hydrogen peroxide for 10 min. The sections were then washed and blocked using blocking solution (Candor Biosciences). After blocking the primary antibodies were applied overnight at 4°C. Next, the sections were washed and probed using biotinylated rabbit-anti-rat secondary antibody (Vector) for 30 min at room temperature. The antigen antibody conjugates were then detected by staining with 3,3′-diaminobenzidine (DAB) . βIIIT and CD44 levels were not quantified. Statistical significance was calculated using the paired student t-test.
Analysis of gene expression and proteomics data
The generation of transcriptomic and proteomic data is reported in detail in the Supplementary Note. Raw microarray data were calibrated and summarized using the RMA method including quantile-normalization (18, 19) . The expression value of each gene was transformed into log10-scale and centered with respect to its mean value averaged over all samples investigated (20) . A relative log expression value of zero indicates that the gene is expressed according to its mean expression value, while positive and negative values refer to over-and under-expression in the data set, respectively.
Gene expression was analysed using the portraying method based on self-organizing map (SOM) data compression. This approach transforms the gene expression patterns of more than 20,000 genes per sample into intuitive quadratic mosaic portraits representing 50x50 grids, in which each tile refers to one microcluster of concertedly expressed genes called 'metagene' (20, 21) . Further analyses were performed either in metagene space, e.g., by clustering concertedly expressed metagenes into so-called spot modules, by calculating group-averaged mean portraits for each cell line and sample condition, or by selecting differential features by calculating difference portraits (Suppl. Fig. 1,2 ) or based on single gene expression data, e.g., by applying gene set enrichment analysis for functional interpretation. The latter approach makes use of the gene set enrichment score (GSZ) which estimates the significance of differential expression of the members of a set of genes compared with the mean expression of all genes in a sample (22) . Gene sets were taken from standard gene ontology (GO) categories or from previous publications as indicated below. All analyses were performed using the R-program opoSOM providing basic SOM portraying in combination with a series of data mining methods and comprehensive visualization options (20) (22) .
Protein data were processed using the same analysis pipeline as described above for gene expression data except for RMA calibration, i.e., the data were log-10 transformed, centralized and subsequently analyzed using the SOM-portraying method.
Suitability of this method for analyzing proteomics data was recently demonstrated (23) .
Statistical analysis
For the functional assays, data are usually representative of experiments performed three times with similar results. Statistical significance for the clonogenicity studies after irradiation or TMZ treatments was assessed with a two-way ANOVA test using the GraphPad Prism 5.0 software. Statistical analysis of cell doubling time and immunofluorescence was calculated using two-tailed student t-test with equal variance while immunohistochemistry data were analysed using two-tailed student t-test with unequal variance, due to the heterogeneous nature of tumors. Survival statistics in the in vivo studies were calculated using the log-rank test from the GraphPad Prism 5.0 software.
Results
Gene expression and proteomics profiling of sphere versus non-sphere cultures of murine glioma cells in vitro
Sphere cultures were established from non-sphere cultures of all four mouse glioma cell lines by switching the non-sphere cultures to NB medium, which resulted in sphere formation in all cell lines (Fig. 1A) . These spheres could be maintained for months under these culture conditions. Microarray-based mRNA expression profiling and mass spectrometry-based proteome analyses were done to assess the gene activity in terms of mRNA and protein abundance, respectively (Supplementary Note). The primary analysis was performed by comparing the expression portraits of all sample classes, i.e., cell lines and culture conditions, obtained from the transcriptome and proteome data, respectively. In contrast to the light microscopic features which were dominated by the culture conditions, the molecular expression landscapes were mainly governed by the respective cell line (Fig. 1B) . For example, each of the SMA lines showed similar gene expression largely independent of the non-sphere or sphere culture condition, reflected also in the similarity tree based on mRNA expression profiles, which also outlines that SMA-560 is less related to the other two, more related SMA lines (Suppl. Fig. 3 ). The proteomic portraits supported this observation for GL-261 whereas the proteomics portraits of the SMA samples revealed clear differences between the sphere culture and non-sphere culture conditions ( Figure 1D , E, Suppl. Fig. 4 ). Non-sphere cultures of the SMA lines were similar whereas GL-261 exhibited a different proteomics profile. Thus, altogether, the similarities between paired non-sphere and sphere cultures were higher than among non-sphere versus sphere cultures, irrespective of whether GL-261 was included or excluded from the analyses.
Expression of stemness markers
Next we performed differential analyses between the samples cultured under nonsphere versus sphere conditions (Suppl. Fig. 1,2) . Both transcriptomics and proteomics data revealed a cluster of mRNA and proteins concertedly down-regulated in nonsphere and upregulated in sphere cultures, depicted as spot profiles in Fig. 1C ,E).
Selected sets of human embryonic stem cell marker genes (24) were selectively upregulated in sphere cultures at mRNA level and even more clearly at protein level ( (Fig. 3A) . Apart from SMA-497 non-sphere and sphere cultures, the mouse glioma cell lines were negative for CD133, and CD133 expression decreased when SMA-497 cells were shifted to sphere culture conditions (Fig. 3B ).
There was also heterogeneous expression of a third stem cell marker, nestin, among non-sphere and sphere cultures: nestin expression decreased in SMA-540 (P=0.0047),
increased by trend in SMA-560 (p=0.16), and remained similar in the other two cell lines (Fig. 3C,D) . Finally, Musashi1 was highly expressed in 3 of the 4 cell lines and essentially unaffected by switching from non-sphere to sphere culture conditions (Fig.   3E,F) .
Expression of markers of neuroglial differentiation markers
The non-sphere cultures expressed neuroglial differentiation markers at variable levels by immunofluorescence microscopy. The astrocytic marker GFAP was highly expressed in SMA-497 and SMA-560, to a lesser degree in GL-261, but not in SMA-540 (Fig.   4A ,B). The neuronal marker βIIIT was expressed in the SMA lines, but only at very low level in GL-261 (Fig. 4C,D) . In contrast, the oligodendroglial marker CNPase was almost uniformly expressed (Fig. 4E,F) . The percentages in Fig. 4B ,D,F illustrate that many cells co-expressed different markers of the different neuroglial lineages. We then determined whether induction of the sphere culture phenotype was associated with decreased expression of these markers. GFAP increased under sphere culture conditions in SMA-540 (P=0.0007) and by trend in GL-261 (P=0.18), whereas CNPase remained highly expressed throughout. Only βIIIT expression uniformly decreased when the cells were induced to undergo sphere formation at the following significance levels:
SMA-497 (P=0.0009), SMA-540 (P= 0.034), SMA-560 (P=0.13) and GL-261 (P=0.093).
Cell growth and clonogenicity of non-sphere versus sphere cultures
Non-sphere cultures of the SMA cell lines had shorter doubling times than sphere cultures at the indicated significance levels: SMA-497 (P=0.03), SMA-540 (P=0.025), SMA-560 (P=0.028). The difference was not significant in GL-261 cells (P=0.067) (Suppl. Fig. 5A-C) . Also, quantification of Ki-67 immunolabeling, a proliferation marker, confirmed higher proliferation of non-sphere cultures for SMA-497 (P=0.019), SMA-540 (P=0.005) and SMA-560 (P=0.015), but not for GL-261 (P=0.3) (Suppl. Fig. 5D-E) . The GSZ score of the gene set 'cell division', taken from the collection of gene ontology (GO) terms 'biological process', in all systems studied confirmed this result at least by trend at the proteomics level: non-sphere conditions were associated with increased activities of the respective genes (Suppl. Fig. 5F ).
Next we assessed the ability for self-renewal in the form of adherent colonies for nonsphere cells or of sphere formation for sphere culture cells, using limiting dilution assays. At similar seeding densities, all non-sphere cultures were superior at selfrenewal to sphere cultures in their respective native culture conditions (Fig. 6A-D) . To distinguish between impact of "cell type" (non-sphere versus sphere cultures) and impact of cell culture conditions (DM versus NB), we performed medium switch experiments in that the non-sphere cells were seeded and cultured in NB medium and the sphere cells in DM medium in the limiting dilution assays. These experiments demonstrated that the DM medium promoted colony formation of sphere cells whereas the colony forming capacity of non-sphere cells diminished to those of sphere cultures when maintained in NB medium ( Fig. 6E-H) .
Differential sensitivity of non-sphere versus sphere cultures to irradiation or TMZ
We next explored the differential sensitivity of non-sphere versus sphere cultures to single fractions of irradiation at 1, 3 or 9 Gy (Fig. 7) or to increasing concentrations of TMZ (Fig. 8) . Effects on survival and reproliferation as well as self-renewal properties were assessed using clonogenic survival and limiting dilution assays. Proliferation of all cell lines was only affected at 9 Gy. Non-sphere and sphere cultures of SMA-497 and SMA-560 were affected similarly whereas SMA-540 sphere cultures (P=0.26) and GL-261 non-sphere cultures (P=0.003) were relatively more radiosensitive (Fig. 7A-D) . Selfrenewal of non-sphere cultures of all cell lines was more affected than that of sphere cultures across the full range of cell numbers seeded (Fig. 7E-H) . Similar assays were performed to study the effect of TMZ. All cell lines were highly resistant to TMZ. At the highest TMZ concentration, the SMA-497 and SMA-540 non-sphere cells were more sensitive than the sphere cells, but not to a significant extent. In contrast, no difference between non-sphere and sphere cultures emerged for SMA-560 or GL-261 ( Fig. 8A-D) .
The self-renewal capacities of non-sphere and sphere cultures after exposure to TMZ at 100 µM were unaffected in all four cell lines at all seeding densities ( Fig. 8E-H) .
Tumorigenicity in syngeneic mice
In order to compare tumorigenicity in vivo, 1,000 non-sphere or sphere cells were injected into the right striatum of syngeneic VM/Dk mice for the SMA cell lines or of C57Bl/6 mice for GL-261 cells. In 3 of 4 cell lines, non-sphere cell implantation produced higher tumor incidences and shorter survival times than sphere cell implantation: the significance levels for the differences of the estimated median survivals were: SMA-497 (P<0.0001), SMA-540 (P=0.0026) and GL-261 (P=0.0005) (Fig. 5A,B,D) . Only in the SMA-560 cell line did the sphere cell-derived tumors kill the animals earlier than non-sphere cell-derived tumors (P<0.0001) (Fig. 5C) . Accordingly, when early stages of tumor development were assessed around day 14 in the SMA and at day 29 in the GL-261 models, non-sphere cells of SMA-497 and SMA-540 and sphere cells of SMA-560 had already developed large tumors and mice were severely symptomatic. Tumors were rather large in GL-261 in both groups at day 29 when the mice became symptomatic (Table 1) CD44 and βIIIT levels were assessed to explore whether some of the differences between non-sphere and sphere cultures in vitro were maintained when these cells were passaged in vivo. This was not the case since CD44 was uniformly expressed in all non-sphere and sphere culture tumors, but not in adjacent brain. In contrast, βIIIT was barely detectable in the tumors, but strongly expressed in normal brain, corresponding to the sphere culture rather than the adherent phenotype in vitro. CD31 labeling reflecting vessel density was similar in both non-sphere and sphere cell tumors of all cell lines, with significantly higher vessel density seen in the sphere cell group only in SMA-560. The SMA-560 tumors were also the most vascularized of all models in general. CD3-labeled T cells were found localized at the tumor periphery (Suppl. Fig.   6A ) and in perivascular regions (Suppl. Fig. 6C ). They were present at higher levels in non-sphere tumors of the SMA models and in the sphere tumors of GL-261. CD11b
infiltration was more prominent in non-sphere than in sphere cell tumors in the SMA models, but not in GL-261 where sphere cell tumors showed higher infiltration. It was found within the tumors and outside the tumor (Suppl. Fig. 6C ) and sometimes in higher densities in areas surrounding blood vessels in GL-261 tumors (Suppl. Fig. 6D ). Overall there was no association of the extent of immune cell infiltration with outcome.
Discussion
The notion that cancers, although of monoclonal origin, are heterogeneous and not Here we addressed the usefulness of stem cells defined by their sphere-forming capacity in a panel of four long-term mouse glioma cell lines. SMA-497, SMA-540 and SMA-560 cells were generated from a spontaneous murine astrocytoma detected in a VM/Dk mouse (15, 17) . GL-261 cells were derived from a tumor generated by implantation of methylcholanthrene pellets in C57Bl/6 mouse brains (16, 28) . Their neuroglial origin was confirmed here by the differential, often co-expression of neuroglial lineage markers such as GFAP, βIIIT and CNPase (Fig. 4) . We found that even after decades of passaging under differentiating (serum-containing) culture conditions, all mouse glioma cell lines had retained the plasticity to grow in spheres with the option of long-term expansion (Fig. 1A) . The sphere culture transcriptomes were uniformly enriched in some stemness-associated genes, including CD44, and such changes from non-sphere to sphere cultures were mostly confirmed at the proteome level.
Up-regulation of one candidate stem cell marker, CD44, a cell surface adhesion protein thought to play a role in tumor progression, has been associated with increased histopathological grade and poorer prognosis in human gliomas as well as increased cell migration and invasiveness in A172 glioma cells (29, 30) . In addition, the expression of CD44 in glioma stem cells has been shown to be controlled by the transforming growth factor-β signalling pathway, which is a target for glioma therapy because of its role in tumor growth (31) . Here, CD44 expression increased in 3 of 4 cell lines under sphere culture conditions, but CD44 was almost lost when SMA-540 were induced to assume a sphere culture phenotype (Fig. 3A) . The classical glioma stem cell marker CD133, which is increasingly questioned regarding its usefulness to delineate stem cells of human glioblastomas (32-34), did not distinguish between sphere and non-sphere cultures in this panel of mouse glioma cell lines (Fig. 3B) . Finally, neither nestin nor Musashi-1 expression correlated with the non-sphere versus sphere culture phenotype ( Fig. 3C-F) . Importantly, our study does not challenge the value of any of these markers to detect stemness because we do not propose that the sphere cultures generated by changing the culture conditions should be considered stem-like.
GFAP, βIIIT and CNPase are commonly used as markers of astrocytic, neuronal, and oligodendroglial differentiation, although GFAP expression is also a radial glial neural stem cell marker (35) . Our analysis of differentiated neural and glial markers showed that sphere culture conditions did not exclusively enrich for a less differentiated, stemlike phenotype, as previously observed (36), as evidenced by the expression of GFAP and CNPase. Of note, the anti-CNPase antibody used here recognizes both the 46kDa
CNPase isoform, present in mature oligodendrocytes, and the 48kDa, both of which were found to be expressed in oligodendrocyte precursor cells in the normal rat brain as well as in C6 glioma cells (37, 38) . By contrast, sphere cultures of all cell lines showed decreased expression of the mature neuronal marker βIIIT (Fig. 4) .
We find that sphere cultures have slowed growth, which we attribute to the deprivation of serum-derived mitogenic stimuli (Suppl. Fig. 5 ). Unexpectedly, sphere cultures from all four cell lines displayed lower self-renewal capacity than non-sphere cultures in limiting dilution assays. Medium switch experiments disclosed that the type of medium rather than a stable sphere culture versus non-sphere trait conferred the increased selfrenewal (Fig. 6 ).
Relative resistance to radiotherapy and chemotherapy, the principal treatment modalities for human glioblastoma patients (39) , is a conceptual hallmark of glioma stem cells. Putatively related to slowed growth kinetics, sphere cultures were uniformly less radiosensitive than non-sphere cultures (Fig. 7) , but both sphere and non-sphere mouse glioma cell cultures were resistant to clinically relevant concentrations of TMZ (Fig. 8) .
Recent studies have highlighted the limitations of using sphere culture conditions to enrich for cancer stem cells (36, 40) . In vivo studies indicated that sphere cells with low self-renewal capacity in vitro generated rapidly developing tumors with higher penetrance compared to more 'stem-like' cells that possessed higher in vitro selfrenewal capacity (41) . Using a limiting cell implantation number approach in order to critically assess the tumorigenicity of sphere cultures versus non-sphere, we find that sphere cultures were not enriched in cells with higher tumorigenic potential in vivo (Fig.   5 ). In fact, non-sphere cultures were more tumorigenic in all but the SMA-560 cell line.
Moreover, we did not observe stable morphological phenotypes defined by proliferative activity or vascular density that would have allowed distinguishing between non-sphere and sphere cell-derived tumors derived from the same cell line, suggesting that the differential culturing in vitro confirmed differential properties for initial seeding and growth in vivo, but did not produce genuinely different tumors. Thus, living in a sphere rather than as a monolayer in vitro is a state rather than a trait of a mouse glioma cell.
Accordingly, the differences in CD44 expression between non-sphere and sphere cultures were not maintained in vivo, and, interestingly, the loss of βIIIT in vivo may indicate that sphere cultures are closer to the in vivo situation than non-sphere cultures. In conclusion, this study provides an extensive characterization of the most commonly used syngeneic mouse glioma models that should guide researchers in selecting such models for their studies. We find no evidence that studies performed with sphere cultures derived from long-term cell lines are biologically more meaningful than studies performed using standard monolayer cultures, at least in the investigated mouse glioma lines. Future studies may need to define whether this holds true for other glioma cell line model systems, too. Importantly, our data must not be used to argue against the increasing use of human stem-like tumor cell lines immediately derived from freshly resected tumor specimens. Gene set enrichment analysis using stemness-related genes (24) shows profiles of the enrichment score for three gene sets in all cell systems studied. The sets contain genes differentially upregulated in hESC9 (A, set hESC9), abundant in hESC (B, hESC10) and myc-regulated targets (C, myc2) (NS, non-sphere cultures, SC sphere cultures). . All counts from all animals were derived to obtain mean and SEM. SMA-540 sphere cells were least tumorigenic. Because of the occurrence of only one incidence of tumor, statistical comparison between the non-sphere and sphere groups could not be made for all stainings done.
